The DOI matches its Crossref record.
Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)
Abstract
Background: 3,4-methylenedioxymethamphetamine (MDMA or ‘Ecstasy’) has become one of the most widely used illicit substances in the UK. Little is known of the psychiatric morbidity which may be associated with its use. We have examined this association by collecting a series of psychiatric cases in which MDMA use was a prominent feature. Method: Patients presenting between 1990 and 1992 with psychiatric symptoms which developed in the context of MDMA use (n= 13) were interviewed, and their psychiatric, medical and drug history, sociodemographic background and mental state were examined in detail. The psychopathology of cases with psychosis (n= 8) was assessed with the Present State Examination and compared with that of substance-naïve psychotic controls (n= 40). Results: Eight patients presented with psychotic syndromes, two experienced visual illusions, hallucinations and palinopsia, one had panic attacks, one suffered from depression, and one described chronic depersonalisation and derealisation. The psychopathology of the patients with psychoses was very similar to that of controls. Conclusions: Use of MDMA may be associated with a broader spectrum of psychiatric morbidity than heretofore suspected. Cases with psychosis may be clinically similar to psychotic patients with no history of substance use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Green, A. R., Cross, A. J., & Goodwin, G. M. (1995) · Psychopharmacology · doi:10.1007/bf02246288 · Cited by 415
Ecstasy (MDMA): a review of its possible persistent psychological effects
Morgan, M. J. (2000) · Psychopharmacology · doi:10.1007/s002130000545 · Cited by 380
Ecstasy use in Australia: patterns of use and associated harm
Topp, L., Hando, J., Dillon, P., Roche, A., & Solowij, N. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00002-2 · Cited by 352
CURRAN, H. V., & TRAVILL, R. A. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02951.x · Cited by 282
Liechti, M. E., & Vollenweider, F. X. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.348 · Cited by 236
Depersonalisation disorder: a cognitive–behavioural conceptualisation
Hunter, E. C. M., Phillips, M. L., Chalder, T., Sierra, M., & David, A. S. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(03)00066-4 · Cited by 185
Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00240 · Cited by 99
Prevalence and childhood antecedents of depersonalization syndrome in a UK birth cohort
Lee, W. E., Kwok, C. H. T., Hunter, E. C. M., Richards, M., & David, A. S. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0327-7 · Cited by 72
Attributions, appraisals and attention for symptoms in depersonalisation disorder
Hunter, E. C. M., Salkovskis, P. M., & David, A. S. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.11.005 · Cited by 39
Metadata
- Authors
- Mcguire, P. K., Cope, H., & Fahy, T. A.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1994-09
- Volume
- 165
- Issue
- 3
- Pages
- 391-395
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2014460982
- Cited by
- 187
- References
- 0
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.